Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

Home Stock Screener Document Search Charting Watchlists Recent Filings

Biogen Inc.(BIIB US)

$253.40+2.921.17%Ext:$262.53+9.133.60%(Market Closed · 00:55:58 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

Financials & Metrics

Financials Charting Short Interest Employees

Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

Home Stock Screener Document Search Charting Watchlists Recent Filings

Biogen Inc.(BIIB US)

$253.40+2.921.17%Ext:$262.53+9.133.60%(Market Closed · 00:55:58 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

Financials & Metrics

Financials Charting Short Interest Employees

BIIB US

BIIB US

Chronological SEC Filings

Chronological SEC Filings

Non-Ownership Filings(741)

10-QQ3ended 30 Sept 202628 Oct
8-KResults of Operations and Financial Condition28 Oct
10-QQ2ended 30 Jun 202629 Jul
8-KResults of Operations and Financial Condition29 Jul
8-KResults of Operations and Financial Condition1 Jul
8-KSubmission of Matters to a Vote of Security Holders10 Jun
8-K/AFinancial Statements and Exhibits10 Jun
8-KBiogen Completes Acquisition of Apellis Pharmaceuticals14 May
SC TO-T/ATender offer statement (third-party, amendment)14 May
SC TO-T/AAMENDMENT NO. 212 May
SC TO-T/AAMENDMENT NO. 16 May
10-QQ1ended 31 Mar 202629 Apr
8-KResults of Operations and Financial Condition29 Apr
ARSAnnual report to security holders28 Apr
DEFA14ADefinitive additional materials28 Apr
DEF 14ADefinitive proxy statement28 Apr
SC TO-TTender offer statement (third-party)14 Apr
SC TO-CSCHEDULE TO7 Apr
8-KResults of Operations and Financial Condition6 Apr
SC TO-CSCHEDULE TO3 Apr

Ownership Filings(1.9K)

SC 13GBIOGEN INC.10 Nov
Form 4Grogan Jane2 Nov
Form 4Godbout Sean5 Oct
Form 4Parini Michael3 Sep
Form 3Parini Michael12 Aug
SC 13G/ABIOGEN INC.6 Aug
Form 4Minor Lloyd5 Aug
Form 144Minor Lloyd4 Aug
Form 144Minor Lloyd3 Aug
Form 4HAWKINS WILLIAM A11 Jun
Form 4SHERWIN STEPHEN A11 Jun
Form 4Rowinsky Eric K11 Jun
Form 4Mantas Jesus B11 Jun
Form 4LANGER SUSAN11 Jun
Form 4Patolawala Monish D11 Jun
Form 4Pangalos Menelas N11 Jun
Form 4Minor Lloyd11 Jun
Form 4Freire Maria C11 Jun
SC 13G/ABIOGEN INC.5 Jun
SC 13D/AApellis Pharmaceuticals, Inc.14 May

Non-Ownership Filings(741)

10-QQ3ended 30 Sept 202628 Oct
8-KResults of Operations and Financial Condition28 Oct
10-QQ2ended 30 Jun 202629 Jul
8-KResults of Operations and Financial Condition29 Jul
8-KResults of Operations and Financial Condition1 Jul
8-KSubmission of Matters to a Vote of Security Holders10 Jun
8-K/AFinancial Statements and Exhibits10 Jun
8-KBiogen Completes Acquisition of Apellis Pharmaceuticals14 May
SC TO-T/ATender offer statement (third-party, amendment)14 May
SC TO-T/AAMENDMENT NO. 212 May
SC TO-T/AAMENDMENT NO. 16 May
10-QQ1ended 31 Mar 202629 Apr
8-KResults of Operations and Financial Condition29 Apr
ARSAnnual report to security holders28 Apr
DEFA14ADefinitive additional materials28 Apr
DEF 14ADefinitive proxy statement28 Apr
SC TO-TTender offer statement (third-party)14 Apr
SC TO-CSCHEDULE TO7 Apr
8-KResults of Operations and Financial Condition6 Apr
SC TO-CSCHEDULE TO3 Apr

Ownership Filings(1.9K)

SC 13GBIOGEN INC.10 Nov
Form 4Grogan Jane2 Nov
Form 4Godbout Sean5 Oct
Form 4Parini Michael3 Sep
Form 3Parini Michael12 Aug
SC 13G/ABIOGEN INC.6 Aug
Form 4Minor Lloyd5 Aug
Form 144Minor Lloyd4 Aug
Form 144Minor Lloyd3 Aug
Form 4HAWKINS WILLIAM A11 Jun
Form 4SHERWIN STEPHEN A11 Jun
Form 4Rowinsky Eric K11 Jun
Form 4Mantas Jesus B11 Jun
Form 4LANGER SUSAN11 Jun
Form 4Patolawala Monish D11 Jun
Form 4Pangalos Menelas N11 Jun
Form 4Minor Lloyd11 Jun
Form 4Freire Maria C11 Jun
SC 13G/ABIOGEN INC.5 Jun
SC 13D/AApellis Pharmaceuticals, Inc.14 May